THE BALANCE Study: Treatment of Hyponatremia Based on Lixivaptan in NYHA Class III/IV Cardiac Patient Evaluation

Phase 3 Completed 652 enrolled CardioKine Inc. Biogen · collab Cardiokine Biopharma, LLC · collab

RandomizedParallel-groupTriple-blindTreatment

Summary

The purpose of this study is to determine the safety and efficacy of lixivaptan in the treatment of hyponatremia in patients with congestive heart failure.

Timeline

Start: 2007-01
Primary completion: 2010-06
Completion: —

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Lixivaptan	Small molecule	—	Oral

Indications

No indication recorded.